Prognostic Factors for Glioblastoma Multiforme: Development of a prognostic index

Survival and prognostic factors of patients with unresectable glioblastoma multiforme.

The aim of this study was to assess survival and prognostic factors of 98 consecutive patients with unresectable glioblastoma multiforme (GBM) after stereotactic biopsy. Patients were diagnosed between 1993 and 1998, and the treatment modality subsequent to stereotactic biopsy was determined by the year of diagnosis. Before 1995, patients did not receive further specific therapy after stereotac...

Prognostic Factors Influencing Clinical Outcomes of Malignant Glioblastoma Multiforme

Malignant glioblastoma multiform (GBM, WHO grade IV) are the most malignant and prevalent intracranial tumor providing for well over one half of all gliomas (Hoffman et al., 2006; Schneider et al., 2010). GBM is characterized by a rapid growth and short time to progression in most treated patients. Current therapeutic modalities include surgical resection, radio-surgical or external irradiation...

Prognostic factors influencing clinical outcomes of glioblastoma multiforme.

BACKGROUND Glioblastoma multiforme (GBM) is the most malignant kind of astrocytic tumors and is associated with a poor prognosis. In this retrospective study, we assessed the clinical, radiological, genetic molecular and treatment factors that influence clinical outcomes of patients with GBM. METHODS A total of 116 patients with GBM who received surgery and radiation between January 2006 and ...

P 20: Neutrophil to Lymphocyte Ratio as a Prognostic Marker in Glioblastoma Multiforme: a Systematic Review and Meta-Analysis

لطفاً به چکیده انگلیسی مراجعه شود.

A Prognostic Model of Glioblastoma Multiforme Using Survival Bayesian Networks